Virtual Reality for Pain Reduction During IUD Insertion
Virtual Reality as a Non-Pharmacological Distraction Intervention During Intrauterine Device Insertion: A Quasi-Experimental Study
1 other identifier
interventional
90
1 country
1
Brief Summary
This study aims to evaluate the effectiveness of virtual reality (VR) as a non-pharmacological distraction intervention during intrauterine device (IUD) insertion. IUD insertion is commonly associated with pain and anxiety, which may negatively affect patient experience and acceptance of the procedure. In this quasi-experimental study, women undergoing IUD insertion were allocated into two groups: a virtual reality group receiving immersive audiovisual distraction during the procedure and a control group receiving standard care. Pain intensity and anxiety levels were assessed and compared between the two groups. The findings of this study are expected to support the use of VR as a safe, simple, and non-invasive method to reduce procedural pain and anxiety and improve patient satisfaction during IUD insertion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedFirst Submitted
Initial submission to the registry
June 9, 2026
CompletedFirst Posted
Study publicly available on registry
June 15, 2026
CompletedJune 15, 2026
June 1, 2026
6 months
June 9, 2026
June 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity measured using Visual Analog Scale (VAS)
Pain intensity will be assessed using a Visual Analog Scale (VAS) ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
During IUD insertion procedure
Secondary Outcomes (1)
State anxiety level measured by the State-Trait Anxiety Inventory (STAI) - State subscale (S-Anxiety)
Baseline (immediately before IUD insertion) and immediately after the procedure
Study Arms (2)
Virtual Reality
EXPERIMENTALParticipants receive virtual reality distraction during intrauterine device insertion.
Control Group
NO INTERVENTIONParticipants receive routine care during intrauterine device insertion without virtual reality.
Interventions
Use of virtual reality headset as a distraction method during IUD insertion.
Eligibility Criteria
You may qualify if:
- Women eligible for intrauterine device (IUD) insertion
- Age between 18 and 45 years
- Willing to participate and provide informed consent
You may not qualify if:
- Contraindications to IUD insertion
- History of severe anxiety disorders
- Previous adverse reaction to virtual reality
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta University Hospital
Tanta, 74322, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Manal Mohammed Ahmed Abdelaziz
Study Record Dates
First Submitted
June 9, 2026
First Posted
June 15, 2026
Study Start
September 1, 2022
Primary Completion
March 1, 2023
Study Completion
March 30, 2023
Last Updated
June 15, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share